Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

16 mars 2020 11h51 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Supports Diagnostic Companies in Fighting Coronavirus Pandemic by Providing Zero Cost Proprietary Technology for Evaluation

CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today its increased commitment to the global fight against COVID-19 by making available zero cost...
16 mars 2020 08h00 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces FDA-Clearance for New Curian™ Analyzer and the Curian™ HpSA® Assay

CINCINNATI, March 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) a provider of immunoassay, molecular, and blood chemistry diagnostic testing solutions, today announced that...
26 févr. 2020 08h00 HE | Source: Meridian Bioscience Inc.

Meridian’s Novel Air-Dryable qPCR Mix Decreases Costs and Simplifies Workflows for Molecular Test Manufacturers

CINCINNATI, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), following the extremely successful launch of the Lyo-Ready qPCR mixes, is proud to introduce today its...
19 févr. 2020 09h15 HE | Source: Meridian Bioscience Inc.; Exalenz Bioscience

Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform

CINCINNATI and MODIIN, Israel, Feb. 19, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) and Exalenz Bioscience Ltd. (TASE: EXEN) announced today that the two companies have entered...
07 févr. 2020 07h30 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports First Quarter Fiscal 2020 Operating Results and Reaffirms 2020 Guidance

CINCINNATI, Feb. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the first quarter ended December 31, 2019. First Quarter Fiscal 2020...
27 janv. 2020 09h17 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Lyo-Ready 1-Step RT-qPCR Mix is Used in the Development of Molecular Diagnostics for New Coronavirus Outbreak

CINCINNATI, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced a novel coronavirus, identified by Chinese authorities on January 7 and currently named...
23 janv. 2020 16h46 HE | Source: Meridian Bioscience Inc.

Meridian เปิดตัวพอลิเมอเรสความแม่นยำสูงแบบใหม่เพื่อให้การเพิ่มจำนวนที่แข็งแกร่งสำหรับประโยชน์ในงานวิเคราะห์ NGS และ PCR

ซินซินนาติ, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) ได้ประกาศในวันนี้ถึงการเปิดตัว High-Specificity Pfu HS Mix ซึ่งไม่เพียงแต่ให้การเพิ่มปริมาณที่มีความแม่นยำสูง...
23 janv. 2020 16h46 HE | Source: Meridian Bioscience Inc.

Meridian lanza nueva polimerasa de alta fidelidad para ofrecer amplificación robusta para aplicaciones NGS y PCR

CINCINNATI, Jan. 23, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) anuncia hoy el lanzamiento de Mix HS de Pfu de Alta Especificidad que además de ofrecer amplificación de alta...
23 janv. 2020 16h46 HE | Source: Meridian Bioscience Inc.

Meridian 推出一種新的高保真聚合酶，可為 NGS 和 PCR 應用提供可靠的擴增

辛辛那提, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) 今天宣佈推出高特異性 Pfu HS Mix，不但可提供高保真擴增，而且提供具有市場領先地位的擴增，用於伴隨診斷 (CDx) 和臨床測試。高保真擴增對於結果取決於正確 DNA 序列的應用至關重要，例如下一代測序...
23 janv. 2020 16h46 HE | Source: Meridian Bioscience Inc.

Meridian推出了一种新的高保真聚合酶，为NGS和PCR应用提供稳健的扩增

辛辛那提, Jan. 24, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience，Inc.（纳斯达克：VIVO）今天宣布推出一种高特异性的Pfu-HS组合，不仅提供高保真度扩增，还为伴诊 (CDx) 和临床试验提供市场领先的扩增。对于结果取决于正确DNA序列的应用（例如下一代测序...

Page précédente

Page suivante